Description

The American Lung Association COVID-19 Action Initiative is a $25M initiative to end COVID-19 and defend against future respiratory virus pandemics.

The initiative will:

• Work with public and private entities to increase research collaboration and develop new vaccines, detection tests and treatment therapies
• Expand the Association’s ongoing respiratory research program by leveraging the Airways Clinical Research Center (ACRC) Network
• Enhance key public health measures
• Establish an advanced network to stop future respiratory virus pandemics

The Lung Association is looking for all types of partners to support the initiative. Partnership opportunities include financial support, cause marketing, sponsorship, grants, in-kind support, employee giving, and more. To learn more about how your company can make an immediate impact on COVID-19 relief efforts, please contact Amanda O’Neill.

“More than 36 million people in the US suffer from lung disease, which places them at higher risk for experiencing complications of COVID-19, making it even more critical that we urgently work on reducing its impact,” said American Lung Association President and CEO Harold Wimmer. “The Lung Association was founded on the principle of using education, advocacy and research to eradicate tuberculosis, and we will use those same principles to ensure our nation can address today’s pandemic and is prepared for future lung infections like COVID-19.”

More information on the association’s COVID-19 Action Initiative can be found here.